[Topical treatment of various dermatosis with difluocortolone valerianate. (ointment) Double blind comparative study].
The trial preparation, diflucortolone valerate, was tested clinically in the form of fatty ointment on 27 patients: 4 with psoriasis, 4 with neurodermatitis, 4 with contact dermatitis, 2 with actinodermatitis, 10 with eczema, 2 with cutaneous reticulosis and 1 with radiodermitis. In 89% of the cases the results were good; in 11% were they regular.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003877:Dermatitis, Contact / Q000188:drug therapy; D004060:Diflucortolone / Q000031:analogs & derivatives; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D014631:Valerates / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D009824:Ointments; D014631:Valerates; C013486:diflucortolone valerate; D004060:Diflucortolone
Tratamiento tópico de algunas dermatósis con valerianato de diflucortolona (ungüento) Estudio doble ciego comparativo